July 25, 2022 Three UNC-Chapel Hill researchers studied the associations between food insecurity, health-related missed workdays and overnight hospitalizations among working-age adults with Type 2 diabetes.
July 25, 2022 Gillings researchers are recognized for work in pharmacoepidemiology, public health leadership and marine environmental sciences, and a recent alumnus receives outstanding dissertation honors.
July 15, 2022 A clinical trial led by the NIH, with support from the Duke Clinical Research Institute and the Gillings School, recently showed that using infliximab or abatacept to treat adults hospitalized with COVID-19 did not shorten recovery time but did improve survival rates.
July 15, 2022 Medicare patients may be bypassing rural hospitals altogether and traveling longer distances to seek care at urban hospitals, according to new research from Hannah Friedman and Dr. Mark Holmes.
July 13, 2022 Imagine a world where racial disparities in health care could be virtually eliminated. Actually, there is no need to imagine — it has already happened at a health care center in Greensboro, North Carolina, for Black and white patients with breast and lung cancer.
July 7, 2022 With the FDA ordering Juul to stop selling their e-cigarette devices, UNC researchers, led by Dr. Ilona Jaspers, published the first study to compare the respiratory immune health effects of different types of devices.
July 6, 2022 Extreme heat events could become more intense and frequent, increasing the risk of harm to health and global economies and deepening climate injustices, according to new research from Dr. Yuqiang Zhang at the Gillings School.
June 29, 2022 Recently published in eBioMedicine, this study represents work that originated with the late Gillings School professor Dr. Steve Meshnick.
June 24, 2022 Removing the Medicaid requirement for prior approval to fill prescriptions for buprenorphine, a common treatment for opioid use disorder, could lead to more patients gaining access to this life-saving medication.
June 23, 2022 Infectious disease expert Dr. David Weber has reached a formidable hallmark: his 50th publication about coronaviruses and COVID-19. His research has played an important role in creating new policies and ways that we can keep ourselves and patients safe in community and hospital settings.
